January 7, 2015 — Discussions regarding late-breaking cardiovascular clinical trials among leading medical scientists ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
December 30, 2014 — Wearable technologies, possible changes to stenting practices, state legislation on energy drinks ...
December 23, 2014 — The most accessed research studies in the Journal of the American College of Cardiology (JACC) in ...
December 16, 2014 — Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio ...
November 25, 2014 — Between 70 and 80 percent of patients with the connective tissue condition Marfan syndrome have ...
November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...
November 12, 2014 — The actions — or inaction — of patients should be considered in programs designed to improve care ...
October 20, 2014 – Heart disease and stroke are the leading causes of death and disability among people with Type 2 ...
October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...
October 14, 2014 — Researchers have discovered a previously unknown cardiac molecule that could provide a key to ...
September 23, 2014 — New analyses and extended follow-up from the BRIGHT study demonstrated that bivalirudin remained ...
September 22, 2014 — According to a new study, patients receiving six months of dual antiplatelet therapy (DAPT) after ...
September 19, 2014 — The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers ...
September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug ...